Literature DB >> 12023334

Ligation of HLA class I molecules on endothelial cells induces phosphorylation of Src, paxillin, and focal adhesion kinase in an actin-dependent manner.

Yi-Ping Jin1, Ram Pyare Singh, Ze-Ying Du, Ayyappan K Rajasekaran, Enrique Rozengurt, Elaine F Reed.   

Abstract

The development of chronic rejection is the major limitation to long-term allograft survival. HLA class I Ags have been implicated to play a role in this process because ligation of class I molecules by anti-HLA Abs stimulates smooth muscle cell and endothelial cell proliferation. In this study, we show that ligation of HLA class I molecules on the surface of human aortic endothelial cells stimulates phosphorylation of Src, focal adhesion kinase, and paxillin. Signaling through class I stimulated Src phosphorylation and mediated fibroblast growth factor receptor (FGFR) translocation to the nucleus. In contrast, Src kinase activity was not involved in class I-mediated transfer of FGFR from cytoplasmic stores to the cell surface. Inhibition of Src protein kinase activity blocked HLA class I-stimulated tyrosine phosphorylation of paxillin and focal adhesion kinase. Furthermore, HLA class I-mediated phosphorylation of the focal adhesion proteins and FGFR expression was inhibited by cytochalasin D and latrunculin A, suggesting a role for the actin cytoskeleton in the signaling process. These findings indicate that anti-HLA Abs have the capacity to transduce activation signals in endothelial cells that may promote the development of chronic rejection.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12023334     DOI: 10.4049/jimmunol.168.11.5415

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  32 in total

1.  A novel pathway of chronic allograft rejection mediated by NK cells and alloantibody.

Authors:  T Hirohashi; C M Chase; P Della Pelle; D Sebastian; A Alessandrini; J C Madsen; P S Russell; R B Colvin
Journal:  Am J Transplant       Date:  2011-11-09       Impact factor: 8.086

2.  HLA class I molecules partner with integrin β4 to stimulate endothelial cell proliferation and migration.

Authors:  Xiaohai Zhang; Enrique Rozengurt; Elaine F Reed
Journal:  Sci Signal       Date:  2010-11-23       Impact factor: 8.192

Review 3.  The link between major histocompatibility complex antibodies and cell proliferation.

Authors:  Nicole M Valenzuela; Elaine F Reed
Journal:  Transplant Rev (Orlando)       Date:  2011-07-30       Impact factor: 3.943

4.  Markers of Endothelial-to-Mesenchymal Transition: Evidence for Antibody-Endothelium Interaction during Antibody-Mediated Rejection in Kidney Recipients.

Authors:  Yi-Chun Xu-Dubois; Julie Peltier; Isabelle Brocheriou; Caroline Suberbielle-Boissel; Arjang Djamali; Shannon Reese; Nuala Mooney; Zela Keuylian; Julien Lion; Nacéra Ouali; Pierre P Levy; Chantal Jouanneau; Eric Rondeau; Alexandre Hertig
Journal:  J Am Soc Nephrol       Date:  2015-05-20       Impact factor: 10.121

5.  Blockade of p-selectin is sufficient to reduce MHC I antibody-elicited monocyte recruitment in vitro and in vivo.

Authors:  N M Valenzuela; L Hong; X-Da Shen; F Gao; S H Young; E Rozengurt; J W Kupiec-Weglinski; M C Fishbein; E F Reed
Journal:  Am J Transplant       Date:  2012-12-27       Impact factor: 8.086

6.  Molecular events contributing to successful pediatric cardiac transplantation in HLA sensitized recipients.

Authors:  Monal Sharma; S A Webber; A Zeevi; T Mohanakumar
Journal:  Hum Immunol       Date:  2019-01-30       Impact factor: 2.850

7.  Antibodies to HLA Molecules Mimic Agonistic Stimulation to Trigger Vascular Cell Changes and Induce Allograft Injury.

Authors:  Nicole M Valenzuela; Elaine F Reed
Journal:  Curr Transplant Rep       Date:  2015-05-24

8.  Key role for CD4 T cells during mixed antibody-mediated rejection of renal allografts.

Authors:  A Gaughan; J Wang; R P Pelletier; T Nadasdy; S Brodsky; S Roy; M Lodder; D Bobek; S Mofatt-Bruce; R L Fairchild; M L Henry; G A Hadley
Journal:  Am J Transplant       Date:  2014-01-10       Impact factor: 8.086

9.  Everolimus inhibits anti-HLA I antibody-mediated endothelial cell signaling, migration and proliferation more potently than sirolimus.

Authors:  Y-P Jin; N M Valenzuela; M E Ziegler; E Rozengurt; E F Reed
Journal:  Am J Transplant       Date:  2014-03-01       Impact factor: 8.086

10.  Report from a consensus conference on the sensitized patient awaiting heart transplantation.

Authors:  Jon Kobashigawa; Mandeep Mehra; Lori West; Ronald Kerman; James George; Marlene Rose; Adriana Zeevi; Nancy Reinsmoen; Jignesh Patel; Elaine F Reed
Journal:  J Heart Lung Transplant       Date:  2009-03       Impact factor: 10.247

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.